- ￥3500
- MedChemExpress(MCE)
- 美国
- HY-18605
- 2025年12月05日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Powder: -20°C, 3 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 库存：
货期：询盘
- 供应商：
MedChemExpress LLC
- CAS号：
1629267-75-9
- 规格：
1 mg
MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。
K-Ras G12C-IN-2
CAS No. : 1629267-75-9
MCE 国际站：K-Ras G12C-IN-2
产品活性：K-Ras G12C-IN-2 是一种不可逆的 K-Ras G12C 抑制剂。
研究领域：GPCR/G Protein
作用靶点：Ras
In Vitro: K-Ras G12C-IN-2 is a covalent kras g12c inhibitor extracted from patent WO2014152588A1, compound V-35.
相关产品：Sotorasib | MRTX1133 | Adagrasib | BI-2852 | BI-3406 | Ketoconazole | NSC 23766 trihydrochloride | BI-2865 | ML141 | BAY-293 | CID-1067700 | Rhosin hydrochloride | Lonafarnib | EHT 1864 | GGTI298 Trifluoroacetate | MBQ-167 | MRTX0902 | Opnurasib | Divarasib | ARS-1620 | CCG-1423 | CASIN | Salirasib | EHop-016 | RMC-6291 | ML-098 | MRTX-1257 | FTI-277 hydrochloride | Pan-RAS-IN-1
热门产品线：重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Detection of K-ras Mutations by a Microelectronic DNA Chip
. These potential molecular tumor markers are essential not only for the diagnosis, prognosis, or the follow-up of the disease but also for the management of therapy (1 ,2 ). Particularly, the K-ras protooncogene is altered, by point mutations within codons
A Novel Method for the Production of Fully Modified K-Ras 4B
post-translationally modified proteins in bacterial expression systems is often problematic. Here, we describe a novel recombinant approach to prepare human K-Ras 4B, a protein that is post-translationally farnesylated
Analysis of K-RAS and P53 Mutations in Sputum Samples
Mutations in the P53 tumor suppressor gene and the K-RAS oncogene have frequently been found in sputum and bronchoalveolar lavage (BAL) samples of lung cancer patients, and also in samples from patients prior to presenting clinical symptoms
技术资料暂无技术资料 索取技术资料
